FRESH

• Research type

  Research Study

• Full title

  Evaluation of fluid volume in patients with sepsis and refractory hypotension

• IRAS ID

  216185

• Contact name

  Lui Forni

• Contact email

  luiforni@nhs.net

• Sponsor organisation

  Cheetah Medical Inc

• Clinicaltrials.gov Identifier

  NCT02837731

• Duration of Study in the UK

  1 years, 0 months, 31 days

• Research summary

  The Cheetah Medical Starling SV device (‘the device’) is being tested as a novel treatment for patients with sepsis and refractory hypotension. This study will determine if assessing fluid responsiveness with the device can lead to less IV fluid being given and improve the outcome of patients with sepsis, compared with the usual standard of care. The ability to measure the heart function before giving IV fluid has proved to have good patient benefit, this study will support this practice.

• REC name

  London - South East Research Ethics Committee

• REC reference

  16/LO/2147

• Date of REC Opinion

  21 Feb 2017

• REC opinion

  Further Information Favourable Opinion